oncolytic polio/rhinovirus recombinant
Biologicalexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2012 (NCT01491893)
Timeline
Indications
Studied for
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- oncolytic polio/rhinovirus recombinant
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02986178 | Phase 2 | Jun 1, 2017 | Duke University |
| NCT01491893 | Phase 1 | Jan 1, 2012 | Duke University, National Cancer Institute (NCI) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Duke University | Academic/Hospital | 2 | 2 | 2 | 2012 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1